首页 > 市场调查报告书 > 製药

循环系统

中风管理市场规模、份额和成长分析（按类型、产品类型、最终用户和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1903221

中风管理市场规模、份额和成长分析（按类型、产品类型、最终用户和地区划分）－2026-2033年产业预测

Stroke Management Market Size, Share, and Growth Analysis, By Type (Ischemic, Hemorrhagic), By Product (Diagnostic Devices, Therapeutic Devices), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月25日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球中风管理市场规模预计到 2024 年将达到 393.8 亿美元，到 2025 年将达到 423.7 亿美元，到 2033 年将达到 761.4 亿美元，预测期（2026-2033 年）的复合年增长率为 7.6%。

全球卒中管理市场趋势凸显了远端医疗和数位健康解决方案的日益融合，显着改善了卒中治疗的可近性。对预防策略和完善的復健计划的重视正在推动患者预后的改善。产业创新体现在血栓清除装置、神经保护剂和个人化治疗方案的进步。然而，卒中治疗可及性方面的差异以及认知度低等挑战依然存在，尤其是在发展中地区。市场正日益接受以患者为中心的综合护理模式，并专注于持续进行旨在优化治疗效果和减少卒中长期影响的研究。这些趋势共同表明，卒中管理是一个充满活力的领域，拥有巨大的成长和改进机会。

全球卒中管理市场驱动因素

先进技术和远端医疗解决方案的日益整合正显着推动全球中风管理市场的发展，该市场在促进早期诊断和有效治疗方面发挥关键作用。这项技术进步不仅简化了卒中病例的管理流程，而且透过及时介入和加强监测，有助于改善患者的预后。随着医疗机构不断采用创新工具和解决方案，卒中治疗的整体效率和效果有望得到提升，最终使患者和整个医疗体係受益。

限制全球卒中管理市场的因素

全球卒中管理市场面临诸多限制因素，阻碍其成长潜力。其中包括某些地区对中风预防和治疗的认知不足，影响了患者的治疗效果和整体市场需求。此外，卒中治疗的高昂费用对许多医疗系统构成重大障碍，使患者无法获得所需的治疗。另外，将先进的卒中管理技术整合到现有医疗基础设施中也面临挑战，这些挑战可能会阻碍市场充分发挥其潜力，从而限制创新和病患服务的改善。

全球中风管理市场趋势

全球卒中管理市场日益呈现出技术进步和创新治疗方法的趋势，旨在改善患者预后并减轻中风负担。远端医疗和数位健康解决方案的整合实现了高效的远端监测和快速干预，而先进的神经影像技术则提高了诊断准确性。微创手术方案（包括血管内血栓切除术）的不断发展，彻底改变了急性中风治疗的模式。此外，药物治疗的突破，例如先进的溶栓药物和神经保护剂，正在提高患者的康復率。加强宣传宣传活动和进行合作倡议，进一步促进了中风的早期发现和风险管理，凸显了各方在改善全球中风预防、管理和復健策略方面所做的共同努力。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2021-2023年营收年比比较

主要企业简介

Medtronic
GE Healthcare
Siemens Healthineers
Philips Healthcare
Boston Scientific Corporation
Abbott Laboratories
Johnson & Johnson
Penumbra, Inc.
Stryker Corporation
Boehringer Ingelheim
AstraZeneca
Pfizer Inc.
Sanofi
Bayer AG
Daiichi Sankyo Company, Limited
F. Hoffmann-La Roche Ltd
Teva Pharmaceuticals
Lupin Pharmaceuticals
Fresenius SE & Co. KGaA
Amneal Pharmaceuticals LLC

结论与建议

简介目录

Product Code: SQMIG35A2508

Global Stroke Management Market size was valued at USD 39.38 Billion in 2024 and is poised to grow from USD 42.37 Billion in 2025 to USD 76.14 Billion by 2033, growing at a CAGR of 7.6% during the forecast period (2026-2033).

Market insights for global stroke management highlight the increasing integration of telemedicine and digital health solutions, significantly improving access to stroke care. Emphasis is placed on preventive strategies and robust rehabilitation programs, fostering better patient outcomes. Innovation within the industry is evident through advancements in clot retrieval devices, neuroprotective agents, and personalized treatment methodologies. Nevertheless, challenges persist, particularly regarding disparities in access and awareness of stroke care in developing regions. The market is increasingly embracing integrated and patient-centric care models, with a strong focus on ongoing research aimed at optimizing treatment outcomes and reducing long-term effects of strokes. These trends collectively position stroke management as a dynamic sector with significant opportunities for growth and improvement.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Stroke Management market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Stroke Management Market Segments Analysis

Global Stroke Management Market is segmented by type, product, end user and region. Based on type, the market is segmented into ischemic, hemorrhagic, transient ischemic attack (TIA) and others. Based on product, the market is segmented into diagnostic devices and therapeutic devices. Based on end user, the market is segmented into hospitals, diagnostic clinics, ambulatory surgery centers and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Stroke Management Market

The global stroke management market is being significantly propelled by the rising integration of advanced technologies and telemedicine solutions, which play a crucial role in facilitating early diagnosis and effective treatment options. This technological advancement not only streamlines the management of stroke cases but also contributes to better patient outcomes through timely interventions and enhanced monitoring. As healthcare providers continue to embrace innovative tools and solutions, the overall efficiency and effectiveness of stroke care are expected to improve, ultimately benefiting patients and the healthcare system as a whole.

Restraints in the Global Stroke Management Market

The global stroke management market faces several limitations that impede its growth potential. These include a lack of awareness about stroke prevention and treatment in certain areas, which affects patient outcomes and overall market demand. Additionally, the high costs associated with stroke treatments present a significant barrier for many healthcare systems, making it difficult for patients to access necessary care. Furthermore, the challenges of integrating advanced stroke management technologies into existing healthcare infrastructures can create obstacles that prevent the market from reaching its full capacity, ultimately limiting innovation and improvement in patient services.

Market Trends of the Global Stroke Management Market

The global stroke management market is increasingly characterized by technological advancements and innovative treatment modalities that aim to enhance patient outcomes and reduce the burden of stroke. The integration of telemedicine and digital health solutions allows for efficient remote monitoring and prompt interventions, while sophisticated neuroimaging techniques enhance diagnostic accuracy. The evolution of minimally invasive surgical options, including endovascular thrombectomy, has transformed the landscape of acute stroke care. Furthermore, breakthroughs in pharmacotherapy, such as advanced clot-dissolving medications and neuroprotective agents, are improving recovery rates. Enhanced awareness campaigns and collaborative research initiatives further drive early detection and risk management, underscoring a collective effort to refine stroke prevention, management, and rehabilitation strategies worldwide.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Stroke Management Market Size by Type & CAGR (2026-2033)

Market Overview
Ischemic
Hemorrhagic
Transient Ischemic Attack (TIA)
Others

Global Stroke Management Market Size by Product & CAGR (2026-2033)

Market Overview
Diagnostic Devices
- Magnetic Resonance Imaging (MRI)
- Computed Tomography Scan (CT scan)
- Electrocardiography
- Carotid Ultrasound
- Cerebral Angiography
- Others
Therapeutic Devices
- Stent Retriever
- Surgical Clips
- Embolic Coils
- Flow Diverters
- Aspiration Catheters
- Others

Global Stroke Management Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Diagnostic Clinics
Ambulatory Surgery Centers
Others

Global Stroke Management Market Size & CAGR (2026-2033)

North America (Type, Product, End User)
- USA
- Canada
Europe (Type, Product, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Product, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Product, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Product, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Philips Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Daiichi Sankyo Company, Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lupin Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius SE & Co. KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amneal Pharmaceuticals LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments